Evidence map›Paper›PMID 29523524›Full record

SynthesisJournal of the American Heart Association2018

Genome Wide Association Study Identifies the

Sonal Singh, Caitrin W McDonough, Yan Gong, Wael A Alghamdi, Meghan J Arwood, Salma A Bargal, Leanne Dumeny, Wen-Yi Li, Mai Mehanna, Bradley Stockard and 12 more

2 registry-linked trialsOpen access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00246519 phase4completednot on this map

Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)

TypeinterventionalSponsorUniversity of FloridaRan2005 to 2010Enrolled1,701ConditionsHypertensionArmsHydrochlorothiazide, Atenolol
NCT01203852 phase4completednot on this map

Pharmacogenomic Evaluation of Antihypertensive Responses 2

TypeinterventionalSponsorUniversity of FloridaRan2010 to 2014Enrolled839ConditionsHypertensionArmsMetoprolol, Chlorthalidone
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pharmacogenomics of Hypertension Treatment.International journal of molecular sciences · 2020
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Sonal SinghDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Caitrin W McDonoughDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Yan GongDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Wael A AlghamdiDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Meghan J ArwoodDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Salma A BargalDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Leanne DumenyDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Wen-Yi LiDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Mai MehannaDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Bradley StockardDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Guang YangDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Felipe A de OliveiraDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Natalie C FredetteDepartment of Pathology, Center of Regenerative Medicine, University of Florida, Gainesville, FL.
Mohamed H ShahinDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Kent R BaileyDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Amber L BeitelsheesDepartment of Medicine, University of Maryland, Baltimore, MD.
Eric BoerwinkleHuman Genetics and Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX.
Arlene B ChapmanSection of Nephrology, University of Chicago, IL.
John G GumsDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
Stephen T TurnerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Rhonda M Cooper-DeHoffDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL dehoff@cop.ufl.edu.
Julie A JohnsonDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL.
University of Florida · USMayo Clinic in Arizona · USMayo Clinic in Florida · USThe University of Texas Health Science Center at Houston · USUniversity of Chicago · USUniversity of Maryland, Baltimore · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Pharmacogenomic Evaluation of Antihypertensive ResponsesU01GM074492 · NIGMS · UNIVERSITY OF FLORIDA · PI JOHNSON, JULIE A. · 2005 to 2014
$20.7M
UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
NCATS NIH HHS UL1 TR000064NCATS NIH HHS UL1 TR000135NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR001427NCATS NIH HHS UL1 TR002378NIGMS NIH HHS U01 GM074492
6 · The paper itself

Abstract

backgroundThiazide and thiazide-like diuretics are first-line medications for treating uncomplicated hypertension. However, their use has been associated with adverse metabolic events, including hyperglycemia and incident diabetes mellitus, with incompletely understood mechanisms. Our goal was to identify genomic variants associated with thiazide-like diuretic/chlorthalidone-induced glucose change. METHODS AND

resultsGenome-wide analysis of glucose change after treatment with chlorthalidone was performed by race among the white (n=175) and black (n=135) participants from the PEAR-2 (Pharmacogenomic Evaluation of Antihypertensive Responses-2). Single-nucleotide polymorphisms with

conclusionsThese results suggest that CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifiers: NCT00246519 and NCT01203852.

Indexed as

Pharmacogenomic VariantsPolymorphism, Single NucleotideAdultAntihypertensive AgentsBiomarkersBlack or African AmericanBlood GlucoseBlood PressureChlorthalidoneEssential HypertensionFemaleGenome-Wide Association StudyHumansHydroxymethylglutaryl-CoA SynthaseHyperglycemiaMaleAntihypertensive AgentsBiomarkersBlood GlucoseChlorthalidoneHMGCS2 protein, humanHydroxymethylglutaryl-CoA SynthaseSodium Chloride Symporter Inhibitorschlorthalidonediabetes mellitusgenome‐wide association studyglucosehydrochlorothiazidehyperglycemiapharmacogenomics

Identifiers

PMID29523524
PMCPMC5907544
OpenAlexW2792233309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.